• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of straninfSexually Transmitted InfectionsCurrent TOCInstructions for authors
Sex Transm Infect. Apr 2002; 78(2): 106–109.
PMCID: PMC1744449

Gonorrhoea in London: usefulness of first line therapies

Abstract

Objectives: To determine the true prevalence and patterns of resistance of Neisseria gonorrhoeae to antimicrobial agents used for therapy in London.

Methods: A longitudinal study of a representative sample of isolates of N gonorrhoeae linked to demographic data of infected patients was undertaken. Isolates were collected from consecutive patients attending genitourinary medicine clinics in the North and South Thames regions of London during 3 months of each of 4 years, 1997–2000. Prevalence of plasmid mediated resistance to penicillin and chromosomally mediated resistance to penicillin and ciprofloxacin was determined by susceptibility testing. The association of antimicrobial resistance among gonococci with sexual orientation of the patient and country of acquisition of infection was determined.

Results: Numbers of gonococcal isolates collected over the same time period between 1997–2000 have increased by 74%. Plasmid mediated resistance to penicillin was low but has risen above 5% in 2000. Chromosomal resistance to penicillin has fallen below the 5% level but total resistance to penicillin, plasmid and chromosomally mediated, was above 5% in all 4 years. The incidence of resistance and reduced susceptibility to the alternative therapeutic choice, ciprofloxacin, is low but numbers are increasing in each year. High level resistance, to both penicillin and ciprofloxacin, has generally been found among heterosexual men and is often acquired abroad. However, there is some evidence of a change to endemic spread in 2000.

Conclusions: This surveillance programme shows that the epidemiology of gonorrhoea in London is changing with increasing numbers and changing patterns of resistance. If gonorrhoea is to be controlled and targets set by the sexual health strategy are to be met, intervention with effective and appropriate antimicrobial agents is essential.

Full Text

The Full Text of this article is available as a PDF (103K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Martin IM, Ison CA. Rise in gonorrhoea in London, UK. London Gonococcal Working Group. Lancet. 2000 Feb 19;355(9204):623–623. [PubMed]
  • Ison CA, Martin IM. Susceptibility of gonococci isolated in London to therapeutic antibiotics: establishment of a London surveillance programme. London Gonococcal Working Group. Sex Transm Infect. 1999 Apr;75(2):107–111. [PMC free article] [PubMed]
  • FitzGerald M, Bedford C. National standards for the management of gonorrhoea. Int J STD AIDS. 1996 Jul;7(4):298–300. [PubMed]
  • Fitzgerald M. Antibiotic treatment for gonorrhoea in the UK. Genitourin Med. 1997 Apr;73(2):149–149. [PMC free article] [PubMed]
  • Goulet V, Sednaoui P, Laporte A, Billy C, Desenclos J-C. The number of gonococcal infections identified by the RENAGO network is increasing. Euro Surveill. 2000 Jan;5(1):2–5. [PubMed]
  • Van der Heyden JH, Catchpole MA, Paget WJ, Stroobant A. Trends in gonorrhoea in nine western European countries, 1991-6. European Study Group. Sex Transm Infect. 2000 Apr;76(2):110–116. [PMC free article] [PubMed]
  • Donovan B, Bodsworth NJ, Rohrsheim R, McNulty A, Tapsall JW. Increasing gonorrhoea reports--not only in London. Lancet. 2000 May 27;355(9218):1908–1908. [PubMed]
  • Sherrard J, Barlow D. PPNG at St Thomas' Hospital--a changing provenance. Int J STD AIDS. 1993 Nov-Dec;4(6):330–332. [PubMed]
  • Young H, Moyes A, Noone A. Epidemiology and treatment outcome of infection with antibiotic resistant strains of Neisseria gonorrhoeae in Scotland. Commun Dis Public Health. 1999 Sep;2(3):198–202. [PubMed]
  • McCutchan JA, Adler MW, Berrie JR. Penicillinase-producing Neisseria gonorrhoeae in Great Britain, 1977-81: alarming increase in incidence and recent development of endemic transmission. Br Med J (Clin Res Ed) 1982 Jul 31;285(6338):337–340. [PMC free article] [PubMed]
  • Morse SA, Lysko PG, McFarland L, Knapp JS, Sandstrom E, Critchlow C, Holmes KK. Gonococcal strains from homosexual men have outer membranes with reduced permeability to hydrophobic molecules. Infect Immun. 1982 Aug;37(2):432–438. [PMC free article] [PubMed]
  • Shafer WM, Balthazar JT, Hagman KE, Morse SA. Missense mutations that alter the DNA-binding domain of the MtrR protein occur frequently in rectal isolates of Neisseria gonorrhoeae that are resistant to faecal lipids. Microbiology. 1995 Apr;141(Pt 4):907–911. [PubMed]
  • Jones RN, Gavan TL, Thornsberry C, Fuchs PC, Gerlach EH, Knapp JS, Murray P, Washington JA., 2nd Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline. J Clin Microbiol. 1989 Dec;27(12):2758–2766. [PMC free article] [PubMed]
  • Forsyth A, Moyes A, Young H. Increased ciprofloxacin resistance in gonococci isolated in Scotland. Lancet. 2000 Dec 9;356(9246):1984–1985. [PubMed]
  • Ison CA, Woodford PJ, Madders H, Claydon E. Drift in susceptibility of Neisseria gonorrhoeae to ciprofloxacin and emergence of therapeutic failure. Antimicrob Agents Chemother. 1998 Nov;42(11):2919–2922. [PMC free article] [PubMed]
  • Ivens D, Martin I, Ison C. Neisseria gonorrhoeae in a London sexually transmitted infection clinic not fully sensitive to quinolones: are isolates imported and how effective is ciprofloxacin as a first-line therapy? Int J STD AIDS. 2000 Dec;11(12):774–776. [PubMed]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Group

Formats:

Related citations in PubMed

See reviews...See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...